Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples

• Published in: Life sciences (1973) Vol. 78; no. 4; pp. 340 - 346
• Main Authors: Chernet, Eyassu, Martin, Laura J., Li, Dominic, Need, Anne B., Barth, Vanessa N., Rash, Karen S., Phebus, Lee A.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 12.12.2005
• Subjects: 5-HT2A; Animals; Antipsychotic Agents - pharmacology; Benzodiazepines - pharmacology; Brain - metabolism; Chromatography, High Pressure Liquid - methods; Clozapine; Clozapine - pharmacology; Dopamine; Dopamine Antagonists - pharmacokinetics; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Evaluation, Preclinical; Fluorobenzenes - pharmacokinetics; Gerbil; Gerbillinae; GR205171; Haloperidol; Haloperidol - pharmacology; In vivo binding; Liquid chromatography; Male; Mass Spectrometry - methods; Mass spectroscopy; MDL-100907; MK-869; Morpholines - pharmacology; Neurokinin; Neurokinin-1 Receptor Antagonists; NK-1; Olanzapine; Piperidines - pharmacokinetics; Raclopride; Raclopride - pharmacokinetics; Rat; Rats; Receptor occupancy; Receptor, Serotonin, 5-HT2A - metabolism; Receptors, Dopamine D2 - metabolism; Receptors, Neurokinin-1 - metabolism; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists - pharmacokinetics; Tetrazoles - pharmacokinetics; Raclopride; Dopamine; Olanzapine; Serotonin; Rat; NK-1; Mass spectroscopy; MDL-100907; In vivo binding; Liquid chromatography; Haloperidol; Clozapine; D2; Neurokinin; MK-869; Receptor occupancy; Gerbil; GR205171; 5-HT2A
• ISSN: 0024-3205; 1879-0631
• DOI: 10.1016/j.lfs.2005.04.075

High performance liquid chromatography combined with either single quad or triple quad mass spectral detectors (LC/MS) was used to measure the brain distribution of receptor occupancy tracers targeting dopamine D2, serotonin 5-HT2A and neurokinin NK-1 receptors using the ligands raclopride, MDL-100907 and GR205171, respectively. All three non-radiolabeled tracer molecules were easily detectable in discrete rat brain areas after intravenous doses of 3, 3 and 30 μg/kg, respectively. These levels showed a differential brain distribution caused by differences in receptor density, as demonstrated by the observation that pretreatment with compounds that occupy these receptors reduced this differential distribution in a dose-dependent manner. Intravenous, subcutaneous and oral dose–occupancy curves were generated for haloperidol at the dopamine D2 receptor as were oral curves for the antipsychotic drugs olanzapine and clozapine. In vivo dose–occupancy curves were also generated for orally administered clozapine, olanzapine and haloperidol at the cortical 5-HT2A binding site. In vivo occupancy at the striatal neurokinin NK-1 binding site by various doses of orally administered MK-869 was also measured. Our results demonstrate the utility of LC/MS to quantify tracer distribution in preclinical brain receptor occupancy studies.